Grant Private Wealth Management Inc Gilead Sciences, Inc. Transaction History
Grant Private Wealth Management Inc
- $176 Billion
- Q2 2025
A detailed history of Grant Private Wealth Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grant Private Wealth Management Inc holds 14,287 shares of GILD stock, worth $1.58 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
14,287Holding current value
$1.58 Million% of portfolio
0.9%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,295Shares Held
1BCall Options Held
9.59MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...